These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 304488

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S, Smith KA.
    J Exp Med; 1977 Aug 01; 146(2):468-82. PubMed ID: 69003
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC, Rodrigues D, Igarashi T.
    J Immunol; 1979 Apr 01; 122(4):1510-8. PubMed ID: 221575
    [No Abstract] [Full Text] [Related]

  • 6. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB, Holden HT, Ting CC, Lavrin DL, Kirchner H.
    Cancer Res; 1976 Feb 01; 36(2 pt 2):615-21. PubMed ID: 56223
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immunity to friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses.
    Ting CC, Bonnard GD.
    J Immunol; 1976 May 01; 116(5):1419-25. PubMed ID: 58034
    [Abstract] [Full Text] [Related]

  • 8. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptive transfer of lymphocytes.
    Ting CC.
    Cell Immunol; 1976 Nov 01; 27(1):71-81. PubMed ID: 136303
    [No Abstract] [Full Text] [Related]

  • 9. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV, Pettey CL, Collins JJ.
    Cancer Res; 1984 Apr 01; 44(4):1489-98. PubMed ID: 6608407
    [Abstract] [Full Text] [Related]

  • 10. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC, Rodrigues D.
    J Immunol; 1980 Mar 01; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanisms of in vivo generation of cytotoxic activity against syngeneic tumours. I. Local differentiation of mature cytotoxic T lymphocytes in the rejection of tumours.
    Tsuru S, Aiso S, Taniguchi M, Zinnaka Y, Nomoto K.
    Immunology; 1985 Feb 01; 54(2):281-8. PubMed ID: 3871419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Humoral regulation of cell-mediated immunity to syngeneic tumor.
    Ting CC.
    Cancer Res; 1976 Oct 01; 36(10):3695-701. PubMed ID: 953995
    [Abstract] [Full Text] [Related]

  • 17. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA, Ruscetti SK, Longo DL, Jacobson S, Brown EJ, Zinn S, Kruisbeek AM.
    J Immunol; 1985 Jul 01; 135(1):703-13. PubMed ID: 2582053
    [Abstract] [Full Text] [Related]

  • 18. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb 01; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 19. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan 01; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 20. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A, Shiku H, Nakayama E.
    J Immunol; 1993 Jun 01; 150(11):4900-10. PubMed ID: 8496592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.